Investor Presentation Updated March 2026 Disclaimer Forward-Looking Statements This presentation has been prepared by Lumexa Imaging Holdings, Inc. ("Lumexa Imaging," the "Company" or "we") and contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, including our guidance fo ...

Group 1 - RadNet, Inc. announced the acquisition of Gleamer SAS for up to €230 million, positioning its subsidiary DeepHealth as the world's largest radiology AI provider [2] - Gleamer reported a 90% annual recurring revenue (ARR) growth rate from 2022 to 2025 and is expected to reach $30 million in ARR by 2026 [2] - The acquisition is structured as an all-cash transaction and integrates FDA-cleared X-ray and musculoskeletal AI into DeepHealth's portfolio, enhancing cost effectiveness and diagnostic automation capabilities [2] Group 2 - Following the acquisition, DeepHealth unveiled a comprehensive native clinical AI portfolio at ECR 2026, integrating Gleamer's AI solutions across various imaging modalities [3] - The new platform aims to establish clinical AI suites for breast, chest, neuro, and prostate care, focusing on earlier disease detection and automated reporting [3] - RadNet, founded in 1981, is the largest U.S. operator of outpatient diagnostic imaging centers, headquartered in California [4]

Company Overview - RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States, based on the number of locations and annual imaging revenue [2] - The company operates a network of owned and/or operated outpatient imaging centers across various states including Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York, Texas, and Virginia [2] - RadNet employs over 11,000 team members, including contracted radiologists, full-time and per diem employees, and technologists [2] Recent Developments - Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026 [1] - The presentation is scheduled for 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) [1] - Simultaneous and archived webcasts of the presentation will be available [2]

Core Viewpoint - RadNet, Inc. is set to present at the 28th Annual Barclays Global Healthcare Conference, highlighting its position as a leader in diagnostic imaging services and digital health solutions [1]. Company Overview - RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States, based on the number of locations and annual imaging revenue [2]. - The company operates a network of outpatient imaging centers across several states, including Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York, Texas, and Virginia [2]. - RadNet employs over 11,000 team members, including full-time and per diem employees, technologists, and contracted radiologists [2]. Presentation Details - The presentation will take place on Thursday, March 12, 2026, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) [1][2]. - The event will be held at the Loews Miami Beach Hotel [2]. - Simultaneous and archived webcasts of the presentation will be available online [2].

Investor Presentation March 2026 Disclaimer Forward-Looking Statements This presentation has been prepared by Lumexa Imaging Holdings, Inc. ("Lumexa Imaging," the "Company" or "we") and contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. T ...

Core Viewpoint - RadNet, Inc. is hosting a conference call on March 5, 2026, to discuss the acquisition of Gleamer SAS and its Digital Health strategy, providing an opportunity for investors to engage with executive management [1]. Company Overview - RadNet, Inc. is a leading provider of diagnostic imaging services in the U.S., operating a network of outpatient imaging centers across multiple states including Arizona, California, and Texas [3]. - The company employs over 11,000 team members, including radiologists and technologists, and offers radiology information technology and AI solutions under the DeepHealth brand [3]. DeepHealth Segment - DeepHealth, a subsidiary of RadNet, focuses on AI-powered health informatics aimed at enhancing imaging care [4]. - The DeepHealth OS is a cloud-first operating system that integrates data across clinical and operational workflows, improving disease detection and clinical outcomes [5]. Gleamer Acquisition - Gleamer, founded in 2017, provides AI solutions for medical imaging, addressing the rising demand due to an aging population and chronic diseases [6]. - The company has analyzed over 30 million exams across 2,250 locations in 44 countries, with its solutions recognized in over 60 peer-reviewed publications [6].

Company Acquisition - RadNet has agreed to acquire Gleamer for up to €230 million ($267.2 million) [1][4] - The acquisition will allow RadNet to access Gleamer's four FDA-approved and six CE-marked radiology AI tools, enhancing diagnostic accuracy and efficiency [2][4] Integration and Workforce - RadNet's health informatics division, DeepHealth, will integrate Gleamer's team of 130 employees and its customer base across 44 countries [3] - Gleamer currently serves over 700 contracts globally, including healthcare systems, hospitals, and imaging centers [3] Service Expansion - The combined portfolio will enable RadNet to offer services in screening, detection, interpretation, and follow-up for neurodegenerative and musculoskeletal conditions, as well as prevalent cancer types [4] - Gleamer's tools are expected to create measurable productivity gains, particularly in X-ray imaging, which constitutes 25% of RadNet's imaging volume [5] Industry Trends - The rise of AI in healthcare is significant, with companies like OpenAI and Anthropic introducing AI-driven healthcare toolkits that may challenge traditional software companies [6] - The imaging and diagnostics sector is increasingly incorporating AI, exemplified by GE Healthcare's launch of next-generation LOGIQ ultrasound systems aimed at streamlining diagnostics and enabling early disease detection [7]

Core Insights - RadNet, Inc. is a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers [1][3] - The company will present at the Raymond James 47 Annual Institutional Investors Conference on March 3, 2026, at 2:15 p.m. Eastern Time [1][2] Company Overview - RadNet operates a network of outpatient imaging centers across several states, including Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York, and Texas [3] - The company is recognized as a leading provider of freestanding, fixed-site diagnostic imaging services in the U.S. based on the number of locations and annual imaging revenue [3] - RadNet employs over 11,000 team members, including contracted radiologists, full-time and per diem employees, and technologists [3]

Financial Data and Key Metrics Changes - Total company revenue increased by 14.8% to $547.7 million, and Adjusted EBITDA increased by 16.9% to $87.7 million compared to the previous year's fourth quarter [8][17] - Digital Health revenue grew by 48.2% to $27.9 million, with Adjusted EBITDA increasing by 8.9% to $4.9 million from the same quarter last year [8][17] - Adjusted earnings per share for RadNet was flat at $0.23 per share compared to $0.04 per share in the previous year's fourth quarter [18] Business Line Data and Key Metrics Changes - Imaging center revenue growth was driven by a 14.1% aggregate and 9.6% same-center advanced imaging procedural volume growth in the fourth quarter [9][10] - Advanced imaging represented 28.6% of RadNet's procedural volume, an increase of 178 basis points from the previous year [9][10] - The Digital Health segment's revenue finished at $92.7 million, exceeding original guidance [19] Market Data and Key Metrics Changes - The company opened seven de novo facilities in 2025 to address backlogs and access points for identified patient populations [10] - 151 of RadNet's 418 centers, or 36.1%, are held within health system partnerships, which have been instrumental in increasing procedural volume [11] Company Strategy and Development Direction - The acquisition of Gleamer is expected to enhance RadNet's digital health business and expand its portfolio of AI-powered solutions [26][34] - The company aims to leverage AI to improve efficiency, productivity, and accuracy in radiology workflows, addressing labor shortages in the industry [12][26] - Future growth is anticipated through further acquisitions and partnerships, particularly in the outpatient imaging sector [11][72] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to grow despite challenges in the labor market and increasing demand for imaging services [42][68] - The company expects to achieve 17%-19% imaging center revenue growth in 2026, driven by same-center performance and new acquisitions [21][22] - Management highlighted the importance of AI in enhancing the capabilities of existing staff rather than replacing them, emphasizing improved patient outcomes [44][45] Other Important Information - At year-end 2025, RadNet's cash balance was $776 million, with a net debt to Adjusted EBITDA leverage ratio of approximately 1.0 [13][20] - The company introduced a new metric, Annual Recurring Revenue (ARR), for the Digital Health segment, which was $75.4 million at the end of 2025 and is expected to approach $140 million by the end of 2026 [24][55] Q&A Session Summary Question: How does RadNet view AI's impact on radiology? - Management believes AI will enhance productivity and accuracy rather than disrupt the workforce, addressing critical needs in radiology [42][44] Question: Can you provide context on the ARR growth? - ARR is expected to grow significantly due to contributions from Gleamer and other acquisitions, with a focus on recurring revenue from contracts [55][56] Question: What efficiency gains are anticipated from the Gleamer acquisition? - The integration of Gleamer's AI capabilities is expected to improve operational efficiency, particularly in routine imaging areas [60][66] Question: Are there more opportunities for joint ventures with hospital systems? - There has been a notable increase in inquiries from hospital systems seeking partnerships, driven by staffing shortages [68][72] Question: What is the expected impact of weather conditions on EBITDA guidance? - Management anticipates labor cost increases and potential impacts from winter weather conditions to be reflected in the EBITDA guidance for 2026 [90][91]

Core Insights - RadNet, Inc. reported a strong financial performance for Q4 2025, with total revenue increasing by 14.8% to a record $547.7 million and adjusted EBITDA rising by 16.9% to $87.7 million, reflecting operational efficiencies and increased demand for imaging services [2][3][5]. Financial Performance - Total Company Revenue for Q4 2025 reached $547.7 million, up from $477.1 million in Q4 2024, marking a 14.8% increase [3][5]. - Adjusted EBITDA for Q4 2025 was $87.7 million, compared to $75.0 million in Q4 2024, representing a 16.9% increase [3][5]. - The Digital Health segment saw revenue growth of 48.2%, reaching $27.9 million in Q4 2025, up from $18.9 million in Q4 2024 [3][6]. - Adjusted EBITDA margins improved by 29 basis points to 16.0% in Q4 2025, compared to 15.7% in Q4 2024 [3]. Operational Highlights - Advanced imaging procedural volumes increased by 14.1% overall, with same-center advanced imaging volumes rising by 9.6% compared to Q4 2024 [3][9]. - The company made significant investments in opening new centers and acquiring existing ones, enhancing its operational capacity [2][3]. - Implementation of DeepHealth technology solutions is aimed at improving efficiencies and reducing costs, with tools like Techlive and See-Mode being rolled out [2][3]. 2026 Guidance - For 2026, RadNet anticipates Imaging Center segment revenue growth of 17%-19% and adjusted EBITDA growth of 18%-22% compared to 2025 [3][19]. - The Digital Health segment is expected to see revenue growth of 46%-56% in 2026, driven by the acquisition of Gleamer and the expansion of AI-powered solutions [3][22][23]. Annual Performance - For the full year 2025, total revenue was $2,040.2 million, an increase of 11.5% from 2024, while adjusted EBITDA rose by 7.4% to $300.2 million [10][11]. - Digital Health revenue for 2025 was $92.7 million, reflecting a 41.1% increase from the previous year [11].